Reduced transcriptional regulation by cisplatin in SKOV3-C1 cells. Scatterplots of all transcripts upregulated (green) or downregulated (red) by cisplatin in SKOV3-NV (A) and SKOV3-C1 (B) were included. Gray area represents filtered genes (fold-change <1.5 in either direction, pâ>â.05). (PPTX 215Â kb
Figure S2. Characterization of primary HGSOC cells and identification of p53 status in primary cells...
Hierarchical clustering was performed using Partek Genomics Suite v6.6. Fold changes for genes in ci...
ST6Gal-I mRNA expression levels after transfection for different time points analyzed in this study....
Overexpression of HE4 suppresses cisplatin-mediated activation of p38 and ERK. (A) SKOV3-NV, SKOV3-C...
Cisplatin induced NF-κB and its physical interaction with PIK3CA promoter in TOV21G and SKOV3 cells....
Figure S1. (A) KLF4 WT or KO PC3 cells were treated with 20Â ÎźM cisplatin at the indicated times. G...
Figure S4. Fn14 inhibits cisplatin resistance in HGSOC primary cancer cells with p53-R248Q. (A)-(C) ...
Figure S1. PCA clustering of splicing inclusion level differences between treated and untreated PDX ...
List of protein identified exclusively in A2780-CisR control (untreated) cells. Table S2. List of pr...
Figure S1. The effects of Fn14 on cisplatin-resistance in HGSOC cells. (A)-(D) Statistical data of W...
Table S1. List of significant genes illustrating enrichment and depletion of genes across 3 ovarian ...
Figure S3. Fn14 inhibits cisplatin resistance in HGSOC primary cancer cells with p53-R248Q. (A)-(D) ...
Figure S6. Overexpression Fn14 alleviates cisplatin resistance in vivo. (A) Statistical data of West...
Figure S5. Fn14 could reduce the formation of Mdm2-p53-R248Q-Hsp90. (A)-(B) Statistical data of West...
Additional file 1: Table 1. Clinicopathological characteristics and expression of circPLPP4 in ovari...
Figure S2. Characterization of primary HGSOC cells and identification of p53 status in primary cells...
Hierarchical clustering was performed using Partek Genomics Suite v6.6. Fold changes for genes in ci...
ST6Gal-I mRNA expression levels after transfection for different time points analyzed in this study....
Overexpression of HE4 suppresses cisplatin-mediated activation of p38 and ERK. (A) SKOV3-NV, SKOV3-C...
Cisplatin induced NF-κB and its physical interaction with PIK3CA promoter in TOV21G and SKOV3 cells....
Figure S1. (A) KLF4 WT or KO PC3 cells were treated with 20Â ÎźM cisplatin at the indicated times. G...
Figure S4. Fn14 inhibits cisplatin resistance in HGSOC primary cancer cells with p53-R248Q. (A)-(C) ...
Figure S1. PCA clustering of splicing inclusion level differences between treated and untreated PDX ...
List of protein identified exclusively in A2780-CisR control (untreated) cells. Table S2. List of pr...
Figure S1. The effects of Fn14 on cisplatin-resistance in HGSOC cells. (A)-(D) Statistical data of W...
Table S1. List of significant genes illustrating enrichment and depletion of genes across 3 ovarian ...
Figure S3. Fn14 inhibits cisplatin resistance in HGSOC primary cancer cells with p53-R248Q. (A)-(D) ...
Figure S6. Overexpression Fn14 alleviates cisplatin resistance in vivo. (A) Statistical data of West...
Figure S5. Fn14 could reduce the formation of Mdm2-p53-R248Q-Hsp90. (A)-(B) Statistical data of West...
Additional file 1: Table 1. Clinicopathological characteristics and expression of circPLPP4 in ovari...
Figure S2. Characterization of primary HGSOC cells and identification of p53 status in primary cells...
Hierarchical clustering was performed using Partek Genomics Suite v6.6. Fold changes for genes in ci...
ST6Gal-I mRNA expression levels after transfection for different time points analyzed in this study....